4 months progress - fin/min/keto/biotin 1/31/2025
A 26-year-old male experienced significant hair regrowth using a 4-in-1 topical treatment from Hims, which includes minoxidil, finasteride, ketoconazole, and biotin, over four months. The user reported increased body and beard hair, skin changes, and no negative sexual side effects, while others noted the rapid and impressive results as atypical.
View this post in the Community →
Similar Community Posts Join
5 / 5 resultscommunity 19 M 5 month update using 7% minoxidil Finasteride 0.3% ketoconazole 2.2% and biotin 0.2% topical solution
A 19-year-old shares a 5-month update on hair loss treatment using 7% minoxidil, finasteride, 0.3% ketoconazole, and 0.2% biotin topical solution, noting crown improvement but continued front hair loss. Others suggest patience and additional treatments like a Derma Stamp for better results.
community (M18) RESULTS SO FAR 1.5 months in, Topical fin 0.3%, ketoconazole 2.2%, minoxidil 7% and biotin 0.2%
An 18-year-old shares progress in hair regrowth after 1.5 months using a topical treatment with finasteride, ketoconazole, minoxidil, and biotin. They report significant hairline improvement and a decrease in sex drive as a side effect.
community 7 months progress. Minoxidil + Dermaroller + Finastride + Biotin + Ketoconazole
The user shared their seven-month hair loss progress using minoxidil, finasteride, biotin, ketoconazole shampoo, and a dermaroller, reporting no side effects and recommending the routine before considering a hair transplant. They use topical treatments daily and wash their hair every two to three days, with plans to continue the routine for another five months.
community 18M 2 months progress, Topical Spray Solution: Finasteride 0.3%, Ketoconazole 2.2%, Minoxidil 7%, Biotin 0.2%
An 18-year-old shares two months of progress using a topical spray solution containing finasteride, ketoconazole, minoxidil, and biotin for hair loss, reporting minimal side effects and satisfaction with results. The user applies the solution daily to different parts of the scalp.
community 5 months 0.3% finasteride / 7% minoxidil. Trust the process lol
A user shared their positive experience with hair regrowth using a topical treatment containing 0.3% finasteride, 7% minoxidil, ketoconazole, and biotin. They noticed results after about three months, experienced some initial shedding, and had minor headaches as a side effect.
Related Research
6 / 6 results
research Controversy: is there a role for adjuvants in the management of male pattern hair loss?
This article reviews current hair loss treatments, proposing a hypothesis that a combination of drugs, supplements, and therapies may effectively manage hair loss, but presents no new clinical results.
research Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men – short version
This guideline review by the European Dermatology Forum evaluates current treatments for androgenetic alopecia but reports no new research findings, aiming to assist dermatologists in selecting safe and effective therapies.
research A Systemic Review on Topical Marketed Formulations, Natural Products, and Oral Supplements to Prevent Androgenic Alopecia: A Review
This review discusses current topical treatments, natural products, and complementary therapies for androgenetic alopecia, but it reports no new clinical results.
research TH07-A New Novel Topical Treatment for Androgenic Alopecia
This article discusses male androgenetic alopecia, describing its progression and pattern, and reports no new findings or clinical results.
research Androgenetic Alopecia: An Evidence-Based Treatment Update
This review concluded that oral finasteride for men and topical minoxidil for both genders have the most evidence supporting their effectiveness and safety for treating androgenetic alopecia.
research Female pattern hair loss: A clinical, pathophysiologic, and therapeutic review
This article discusses treatments for female pattern hair loss, highlighting that oral antiandrogens and topical minoxidil can effectively arrest progression and reverse miniaturization in many patients with mild-to-moderate cases, but it reports no new clinical results.